Poison Arrow 2024 a Series of Nor'easter Capital LLC (CIK: 0002064013) EDGAR, Information, Filings... CompaniesBIO.Com

Poison Arrow 2024 a Series of Nor'easter Capital LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Poison Arrow 2024 a Series of Nor'easter Capital LLC (CIK: 0002064013) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. Poison Arrow 2024 a Series of Nor'easter Capital LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Poison Arrow 2024 a Series of Nor'easter Capital LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002064013-25-000001 (33 Act) Size: KB	Apr-09-2025	021-543274 25824661

Recent 20 filings. View all Poison Arrow 2024 a Series of Nor'easter Capital LLC filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Poison Arrow 2024 a Series of Nor'easter Capital LLC overview
Poison Arrow 2024 a Series of Nor'easter Capital LLC job
Poison Arrow 2024 a Series of Nor'easter Capital LLC stock
Poison Arrow 2024 a Series of Nor'easter Capital LLC ownership
Poison Arrow 2024 a Series of Nor'easter Capital LLC CEO
Poison Arrow 2024 a Series of Nor'easter Capital LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.